188 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Blood Platelet Disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Thrombocytopathy in Gaucher Disease Patients
Conditions: Gaucher Disease;   Thrombocytopathy
Intervention:
2 Recruiting Effects of Exercise Training on Cardiovascular Health in Middle-aged Women
Conditions: Menopause;   Cardiac Function Impaired;   Cardiovascular Diseases;   Blood Platelet Disorders;   Metabolic Diseases
Interventions: Behavioral: Yoga/Pilates;   Behavioral: Spinning
3 Recruiting A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Conditions: Primary Myelofibrosis;   Thrombocythemia, Essential;   Thrombocytosis;   Myeloproliferative Disorders;   Bone Marrow Diseases;   Hematologic Diseases;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hemorrhagic Disorders
Interventions: Drug: LDE225;   Drug: INC424
4 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
5 Not yet recruiting Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy
Conditions: Hemorrhage, Surgical;   Hip Replacement, Total;   Thrombocytopathy
Interventions: Drug: Gelofusine® B. Braun;   Drug: Ringerfundin ® B. Braun
6 Recruiting Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
7 Recruiting Eltrombopag for Inherited Thrombocytopenias
Condition: Inherited Platelet Disorder
Intervention: Drug: Eltrombopag
8 Recruiting Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Conditions: Primary Myelofibrosis;   Post-polycythemia Vera Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Pacritinib;   Drug: Best Available Therapy
9 Recruiting ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Second Line ITP agents
10 Recruiting Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
Condition: Platelet Dysfunction
Intervention: Drug: desmopressin
11 Recruiting Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets
Condition: Platelet Dysfunction
Intervention: Other: Blood punction
12 Not yet recruiting Prospective Study of Patients With Thrombocytopenia Following HSCT
Conditions: Thrombocytopenia;   Hematologic Diseases
Interventions: Drug: decitabine;   Drug: rhTPO
13 Recruiting Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: plasma-derived FVIII/VWF concentrate Fanhdi
14 Not yet recruiting Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
Condition: Von Willebrands Disease
Intervention:
15 Recruiting Complement Inhibition in aHUS Dialysis Patients
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: CCX168
16 Not yet recruiting Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Condition: Thrombocytopenia
Interventions: Drug: Hydroxychloroquine;   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
17 Recruiting Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease
Condition: Myelofibrosis
Interventions: Drug: Idelalisib;   Drug: Ruxolitinib
18 Recruiting Study of Nivolumab in Patients With Myelofibrosis
Condition: Myeloproliferative Diseases
Interventions: Drug: Nivolumab;   Behavioral: Questionnaire;   Behavioral: Phone Call
19 Recruiting Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Interventions: Drug: RG7388;   Drug: Pegasys
20 Recruiting A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Hetrombopag Olamine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years